Keyman188 Further reminder before making any further decision...
Quarter on Quarter revenue decelerated by 6.62 percent Quarter on Quarter net profit decelerated by 12.63 percent
Non-growth stock... (not consistent growth...no matter Ebitda or nett profits to SH not consistent for the past 5 years)...
Non-value stock...(current share price consider high valuation due to high Pe by around 27 times)...
Latest financial performance NOT so excited...
Keyman188 re-search retains Sell call on the stock with an unchanged Tp of RM2.00 (ex-bonus : RM1.50) based on a CY22F Pe of 20 times (+1 standard deviations from its five-year mean), the Keyman188 re-search house highlighted.
5c (lima sen sahaja) from 2.00 and that's your satisfaction? Low gratifications levels..hahaha
The engine has started and we will see some fireworks. Prepare for launching, even though this is a GLC. The accumulation is almost complete and just need a match!
After losing both parents and their grandma a week before, these kids are orphaned and robbed of family and future. More than 4,400 kids made orphans under this Pandemic, but they have not taken responsibilities and made changes earlier. There are now daily deaths of >300 and cases still above 15K.
No doubt Dpharma is a laggard. Absolutely right on this claim.
But, may we know how great is Pharma? Investors still trapped at 7.00, high of 7.25 and ex bonus at 5.25 (1.05 on 4 : 1 bonus) Current price at 81c (4.05 pre-bonus)
Further reminder before making any further decision...
Non-growth stock...(not consistent growth...no matter EBITDA or NP to SH not consistent for the past 5 years)...
Non-value stock...(current share price consider high valuation due to high PE by around 27 times)...
Latest financial performance NOT so excited...
QoQ revenue decelerated by 6.62%
QoQ net profit decelerated by 12.63%
"We retain our SELL call on the stock with an unchanged TP of RM2.00 (ex-bonus : RM1.50) based on a CY22F P/E of 20 times (+1 standard deviations from its five-year mean),” the Keyman188 research house highlighted.
Further reminder before making any further decision...
Non-growth stock...(not consistent growth...no matter EBITDA or NP to SH not consistent for the past 5 years)...
Non-value stock...(current share price consider high valuation due to high PE by around 27 times)...
Latest financial performance NOT so excited...
QoQ revenue decelerated by 6.62%
QoQ net profit decelerated by 12.63%
"We retain our SELL call on the stock with an unchanged TP of RM2.00 (ex-bonus : RM1.50) based on a CY22F P/E of 20 times (+1 standard deviations from its five-year mean),” the Keyman188 research house highlighted.
New IPO: Carlo Rino Group Berhad, a leading fashion retailer of women’s handbags, footwear, and accessories, aims to list on the ACE Market!
MQ Trader 86 views | 15 h ago
0:17
New IPO: A homegrown air fragrance company, Vanzo Holdings Berhad aims to list on the Ace Market!
MQ Trader 214 views | 1 d ago
0:17
New IPO: Winstar Capital Berhad, a specialist in the extrusion of aluminium profiles and fabrication of aluminium ladders aims to list on the ACE Market!
MQ Trader 380 views | 2 d ago
0:17
New IPO: Topvision Eye Specialist Berhad, specializing in medical eye care services aims to list on the ACE Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Juliana
5,395 posts
Posted by Juliana > 2021-09-11 08:40 | Report Abuse
Why?